Facebook
X
LinkedIn
ForwardHLA Antibody Testing & Management in the Pediatric Heart Transplant Population
Unit based in-service activity collaborating with heart transplant coordinators to expand knowledge related to HLA antibodies and pediatric transplant patients
Target Audience
Nurse
Learning Objectives
Following this session:
- Learners will be able to identify one consideration related to HLA Antibody process (lab, treatment, etc.)
- Learners will be able to identify a consideration for treatment of pediatric heart transplant rejection.
- Learners will be able to identify a consideration for pre transplant HLA antibody testing in relation to transplant outcomes for rejection
Allison Huston, Transplant Coordinator
Conflict of Interest Disclosure:
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Available Credit
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation